2017
DOI: 10.4067/s0717-73482017000200137
|View full text |Cite
|
Sign up to set email alerts
|

Avances en el tratamiento de la tuberculosis multirresistente

Abstract: Advances in the treatment of multi-drug resistant tuberculosis Therapy of multi-drug resistant tuberculosis (MDR TB) is based on trials with drugs with highly variable patterns of resistance and non-standardized follow-ups that make it difficult to provide recom- Resumen El tratamiento de las tuberculosis multidrogorresistentes (TBC-MDR) se basa en esquemas de fár-macos con diseños muy variables, en pacientes con patrones de resistencia heterogéneos y seguimientosIntroducción la tBC-MDr (resistente a isoniacid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0
2

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
0
0
2
Order By: Relevance
“…Também sendo testados na TB sensível visando diminuir o tempo de tratamento e favorecer a adesão terapêutica. (PENA & FARGA, 2017).…”
Section: Perspectivas E Avanços No Desenvolvimento De Fármacos Contraunclassified
“…Também sendo testados na TB sensível visando diminuir o tempo de tratamento e favorecer a adesão terapêutica. (PENA & FARGA, 2017).…”
Section: Perspectivas E Avanços No Desenvolvimento De Fármacos Contraunclassified
“…Las más utilizadas son el levofloxacino y el moxifloxacino. Sus efectos adversos más conocidos son la prolongación del intervalo QT y la tendinitis 62.…”
unclassified